Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard? (Q80609112)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

Single agent fluorouracil for first-line treatment of advanced colorectal cancer as standard? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Hans-Joachim Schmoll

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

English

0 references

publication date

1 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

9582

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

105-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

Management of advanced colorectal cancer: state of the art.

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961062-9

7 January 2021

The price tag on progress--chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961062-9

7 January 2021

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961062-9

7 January 2021

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961062-9

7 January 2021

Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961062-9

7 January 2021

FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic O

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961062-9

7 January 2021

Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologi

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961062-9

7 January 2021

10.1016/S0140-6736(07)61062-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17630019%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference